Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US8740602052
12,80 € ↓ -0,10 (-0,78%)
2026-06-04
DEL PRIS
SecurityDE:TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
InstitutionRosenberg Matthew Hamilton
Latest Disclosed Ownership1,723 shares
Latest Disclosed Value $ 31,902
Rosenberg Matthew Hamilton ownership in TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)

On April 6, 2026 - Rosenberg Matthew Hamilton filed a 13F-HR form disclosing ownership of 1,723 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock) (DE:TKDA) valued at $27,223 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 5, 2026 disclosing 1,723 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $22,054 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-06 2026-03-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 1,723 0 0.00 32 19.23 0.0065
2026-01-05 2025-12-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 1,723 0 0.00 27 4.00 0.0056
2025-11-10 2025-09-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 1,723 -381 -18.11 25 -21.87 0.0055
2025-07-28 2025-06-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,104 0 0.00 33 3.23 0.0076
2025-04-28 2025-03-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,104 0 0.00 31 14.81 0.0078
2025-01-14 2024-12-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,104 0 0.00 28 -6.90 0.0072
2024-10-28 2024-09-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,104 543 34.79 30 45.00 0.0078
2024-07-26 2024-06-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 1,561 -1,086 -41.03 20 -44.44 0.0060
2024-04-22 2024-03-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,647 0 0.00 36 -2.70 0.0105
2024-01-16 2023-12-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,647 -729 -21.59 38 -28.85 0.0116
2023-10-11 2023-09-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 3,376 337 11.09 52 10.64 0.0174
2023-07-26 2023-06-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 3,039 321 11.81 48 6.82 0.0161
2023-04-17 2023-03-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,718 0 0.00 45 4.76 0.0145
2023-01-19 2022-12-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,718 11 0.41 42 20.00 0.0144
2022-10-21 2022-09-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,707 13 0.48 35 -7.89 0.0135
2022-07-15 2022-06-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,694 0 0.00 38 -2.56 0.0143
2022-04-14 2022-03-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,694 0 0.00 39 5.41 0.0136
2022-01-20 2021-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 2,694 -5,179 -65.78 37 -71.32 0.0132
2021-10-12 2021-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 7,873 462 6.23 129 3.20 0.0510
2021-07-26 2021-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 7,411 477 6.88 125 -1.57 0.0651
2021-04-30 2021-03-31 13F TAKEDA PHARMACEUTICAL LTD SPONSORED ADS 874060205 6,934 586 9.23 127 10.43 0.0725
2021-02-03 2020-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 6,348 -2,360 -27.10 115 -25.81 0.0718
2020-10-16 2020-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 8,708 10 0.11 155 -0.64 0.1139
2020-08-04 2020-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 8,698 3,155 56.92 156 83.53 0.1242
2020-05-14 2020-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 5,543 5,543 85 0.0845
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.